APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genome Annotation Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Genome Annotation Service Market Analysis and Forecast 2026-2032

3 May 2026200 pages

Choose your research edition.

Industry ResearchGenome Annotation Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Genome Annotation Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Genome Annotation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genome Annotation Service Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Genome Annotation Service Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Genome Annotation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Genome Annotation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Genome Annotation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Genome Annotation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Genome Annotation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Genome Annotation Service include Charles River, Lexogen, Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp and Berry Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Genome Annotation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Genome Annotation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Genome Annotation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genome Annotation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Genome Annotation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Genome Annotation Service revenue, projected growth trends, production technology, application and end-user industry.

Genome Annotation Service Segment by Company

Charles River

Lexogen

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

Genome Annotation Service Segment by Type

RAST Tool Kit

Viral Genome ORF Reader

Genome Annotation Service Segment by Application

Hospitals and Clinics

Biopharma Companies

Academic & Research Organizations

Others

Genome Annotation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Annotation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genome Annotation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Annotation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Genome Annotation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Genome Annotation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genome Annotation Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Genome Annotation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. RAST Tool Kit Major Player Table 3. Viral Genome ORF Reader Major Player Table 4. Global Genome Annotation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals and Clinics Major Player Table 6. Biopharma Companies Major Player Table 7. Academic & Research Organizations Major Player Table 8. Others Major Player Table 9. Genome Annotation Service Industry Trends Table 10. Genome Annotation Service Industry Drivers Table 11. Genome Annotation Service Industry Opportunities and Challenges Table 12. Genome Annotation Service Industry Restraints Table 13. Global Genome Annotation Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Genome Annotation Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Genome Annotation Service Market Share by Region (2021-2026) Table 16. Global Genome Annotation Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Genome Annotation Service Market Share by Region (2027-2032) Table 18. Global Genome Annotation Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Genome Annotation Service Revenue Market Share by Players (2021-2026) Table 20. Global Genome Annotation Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Genome Annotation Service Key Players Headquarters & Area Served Table 22. Global Genome Annotation Service Players, Product Type & Application Table 23. Global Genome Annotation Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Genome Annotation Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Genome Annotation Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Genome Annotation Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Genome Annotation Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Genome Annotation Service Revenue Market Share by Type (2021-2026) Table 30. Global Genome Annotation Service Revenue Market Share by Type (2027-2032) Table 31. Global Genome Annotation Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Genome Annotation Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Genome Annotation Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Genome Annotation Service Revenue Market Share by Application (2021-2026) Table 35. Global Genome Annotation Service Revenue Market Share by Application (2027-2032) Table 36. Charles River Company Information Table 37. Charles River Business Overview Table 38. Charles River Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Charles River Genome Annotation Service Product Portfolio Table 40. Charles River Recent Development Table 41. Lexogen Company Information Table 42. Lexogen Business Overview Table 43. Lexogen Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Lexogen Genome Annotation Service Product Portfolio Table 45. Lexogen Recent Development Table 46. Eurofins Scientific Company Information Table 47. Eurofins Scientific Business Overview Table 48. Eurofins Scientific Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Eurofins Scientific Genome Annotation Service Product Portfolio Table 50. Eurofins Scientific Recent Development Table 51. Natera Company Information Table 52. Natera Business Overview Table 53. Natera Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Natera Genome Annotation Service Product Portfolio Table 55. Natera Recent Development Table 56. BGI Company Information Table 57. BGI Business Overview Table 58. BGI Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. BGI Genome Annotation Service Product Portfolio Table 60. BGI Recent Development Table 61. Illumina Company Information Table 62. Illumina Business Overview Table 63. Illumina Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Illumina Genome Annotation Service Product Portfolio Table 65. Illumina Recent Development Table 66. Roche Company Information Table 67. Roche Business Overview Table 68. Roche Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Roche Genome Annotation Service Product Portfolio Table 70. Roche Recent Development Table 71. LabCorp Company Information Table 72. LabCorp Business Overview Table 73. LabCorp Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. LabCorp Genome Annotation Service Product Portfolio Table 75. LabCorp Recent Development Table 76. Berry Genomics Company Information Table 77. Berry Genomics Business Overview Table 78. Berry Genomics Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Berry Genomics Genome Annotation Service Product Portfolio Table 80. Berry Genomics Recent Development Table 81. Brooks Life Sciences Company Information Table 82. Brooks Life Sciences Business Overview Table 83. Brooks Life Sciences Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Brooks Life Sciences Genome Annotation Service Product Portfolio Table 85. Brooks Life Sciences Recent Development Table 86. Macrogen Company Information Table 87. Macrogen Business Overview Table 88. Macrogen Genome Annotation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Macrogen Genome Annotation Service Product Portfolio Table 90. Macrogen Recent Development Table 91. Personalis Company Information Table 92. Personalis Business Overview Table 93. Personalis Genome Annotation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Personalis Genome Annotation Service Product Portfolio Table 95. Personalis Recent Development Table 96. Novogene Company Information Table 97. Novogene Business Overview Table 98. Novogene Genome Annotation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Novogene Genome Annotation Service Product Portfolio Table 100. Novogene Recent Development Table 101. Genotypic Technology Company Information Table 102. Genotypic Technology Business Overview Table 103. Genotypic Technology Genome Annotation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Genotypic Technology Genome Annotation Service Product Portfolio Table 105. Genotypic Technology Recent Development Table 106. Dna Link Company Information Table 107. Dna Link Business Overview Table 108. Dna Link Genome Annotation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Dna Link Genome Annotation Service Product Portfolio Table 110. Dna Link Recent Development Table 111. North America Genome Annotation Service Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Genome Annotation Service Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Genome Annotation Service Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Genome Annotation Service Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Genome Annotation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Genome Annotation Service Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Genome Annotation Service Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Genome Annotation Service Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Genome Annotation Service Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Genome Annotation Service Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Genome Annotation Service Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Genome Annotation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Genome Annotation Service Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Genome Annotation Service Revenue by Country (US$ Million) & (2027-2032) Table 125. China Genome Annotation Service Revenue by Type (2021-2026) & (US$ Million) Table 126. China Genome Annotation Service Revenue by Type (2027-2032) & (US$ Million) Table 127. China Genome Annotation Service Revenue by Application (2021-2026) & (US$ Million) Table 128. China Genome Annotation Service Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Genome Annotation Service Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Genome Annotation Service Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Genome Annotation Service Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Genome Annotation Service Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Genome Annotation Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Genome Annotation Service Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Genome Annotation Service Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Genome Annotation Service Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Genome Annotation Service Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Genome Annotation Service Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Genome Annotation Service Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Genome Annotation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Genome Annotation Service Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Genome Annotation Service Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Genome Annotation Service Image Figure 2. Global Genome Annotation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genome Annotation Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. RAST Tool Kit Image Figure 5. Viral Genome ORF Reader Image Figure 6. Global Genome Annotation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Genome Annotation Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals and Clinics Image Figure 9. Biopharma Companies Image Figure 10. Academic & Research Organizations Image Figure 11. Others Image Figure 12. Global Genome Annotation Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Genome Annotation Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Genome Annotation Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Genome Annotation Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Genome Annotation Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Genome Annotation Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Genome Annotation Service Revenue Market Share by Type (2021-2032) Figure 20. Global Genome Annotation Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Genome Annotation Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Genome Annotation Service Revenue Market Share by Application (2021-2032) Figure 23. North America Genome Annotation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Genome Annotation Service Revenue Share by Type (2021-2032) Figure 25. North America Genome Annotation Service Revenue Share by Application (2021-2032) Figure 26. North America Genome Annotation Service Revenue Share by Country (2021-2032) Figure 27. United States Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Genome Annotation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Genome Annotation Service Revenue Share by Type (2021-2032) Figure 32. Europe Genome Annotation Service Revenue Share by Application (2021-2032) Figure 33. Europe Genome Annotation Service Revenue Share by Country (2021-2032) Figure 34. Germany Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Genome Annotation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Genome Annotation Service Revenue Share by Type (2021-2032) Figure 44. China Genome Annotation Service Revenue Share by Application (2021-2032) Figure 45. Asia Genome Annotation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Genome Annotation Service Revenue Share by Type (2021-2032) Figure 47. Asia Genome Annotation Service Revenue Share by Application (2021-2032) Figure 48. Asia Genome Annotation Service Revenue Share by Region (2021-2032) Figure 49. Japan Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Genome Annotation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Genome Annotation Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Genome Annotation Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Genome Annotation Service Revenue Share by Country (2021-2032) Figure 59. Brazil Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Genome Annotation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • RAST Tool Kit
  • Viral Genome ORF Reader
Applications
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
Companies covered
  • Charles River
  • Lexogen
  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Brooks Life Sciences
  • Macrogen
  • Personalis
  • Novogene
  • Genotypic Technology
  • Dna Link

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Genome Annotation Service Market by Type
  3. 1.2.1 Global Genome Annotation Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 RAST Tool Kit
  5. 1.2.3 Viral Genome ORF Reader
  6. 1.3 Genome Annotation Service Market by Application
  7. 1.3.1 Global Genome Annotation Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals and Clinics
  9. 1.3.3 Biopharma Companies
  10. 1.3.4 Academic & Research Organizations
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Genome Annotation Service Market Dynamics
  1. 2.1 Genome Annotation Service Industry Trends
  2. 2.2 Genome Annotation Service Industry Drivers
  3. 2.3 Genome Annotation Service Industry Opportunities and Challenges
  4. 2.4 Genome Annotation Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Genome Annotation Service Market Perspective (2021-2032)
  2. 3.2 Global Genome Annotation Service Growth Trends by Region
  3. 3.2.1 Global Genome Annotation Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Genome Annotation Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Genome Annotation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Genome Annotation Service Revenue by Players
  2. 4.1.1 Global Genome Annotation Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Genome Annotation Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Genome Annotation Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Genome Annotation Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Genome Annotation Service Key Players Headquarters & Area Served
  7. 4.4 Global Genome Annotation Service Players, Product Type & Application
  8. 4.5 Global Genome Annotation Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Genome Annotation Service Market CR5 and HHI
  11. 4.6.3 2025 Genome Annotation Service Tier 1, Tier 2, and Tier 3
5 Genome Annotation Service Market Size by Type
  1. 5.1 Global Genome Annotation Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Genome Annotation Service Revenue by Type (2021-2032)
  3. 5.3 Global Genome Annotation Service Revenue Market Share by Type (2021-2032)
6 Genome Annotation Service Market Size by Application
  1. 6.1 Global Genome Annotation Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Genome Annotation Service Revenue by Application (2021-2032)
  3. 6.3 Global Genome Annotation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River
  2. 7.1.1 Charles River Company Information
  3. 7.1.2 Charles River Business Overview
  4. 7.1.3 Charles River Genome Annotation Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River Genome Annotation Service Product Portfolio
  6. 7.1.5 Charles River Recent Developments
  7. 7.2 Lexogen
  8. 7.2.1 Lexogen Company Information
  9. 7.2.2 Lexogen Business Overview
  10. 7.2.3 Lexogen Genome Annotation Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lexogen Genome Annotation Service Product Portfolio
  12. 7.2.5 Lexogen Recent Developments
  13. 7.3 Eurofins Scientific
  14. 7.3.1 Eurofins Scientific Company Information
  15. 7.3.2 Eurofins Scientific Business Overview
  16. 7.3.3 Eurofins Scientific Genome Annotation Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eurofins Scientific Genome Annotation Service Product Portfolio
  18. 7.3.5 Eurofins Scientific Recent Developments
  19. 7.4 Natera
  20. 7.4.1 Natera Company Information
  21. 7.4.2 Natera Business Overview
  22. 7.4.3 Natera Genome Annotation Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Natera Genome Annotation Service Product Portfolio
  24. 7.4.5 Natera Recent Developments
  25. 7.5 BGI
  26. 7.5.1 BGI Company Information
  27. 7.5.2 BGI Business Overview
  28. 7.5.3 BGI Genome Annotation Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BGI Genome Annotation Service Product Portfolio
  30. 7.5.5 BGI Recent Developments
  31. 7.6 Illumina
  32. 7.6.1 Illumina Company Information
  33. 7.6.2 Illumina Business Overview
  34. 7.6.3 Illumina Genome Annotation Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Illumina Genome Annotation Service Product Portfolio
  36. 7.6.5 Illumina Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche Genome Annotation Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Roche Genome Annotation Service Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 LabCorp
  44. 7.8.1 LabCorp Company Information
  45. 7.8.2 LabCorp Business Overview
  46. 7.8.3 LabCorp Genome Annotation Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 LabCorp Genome Annotation Service Product Portfolio
  48. 7.8.5 LabCorp Recent Developments
  49. 7.9 Berry Genomics
  50. 7.9.1 Berry Genomics Company Information
  51. 7.9.2 Berry Genomics Business Overview
  52. 7.9.3 Berry Genomics Genome Annotation Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Berry Genomics Genome Annotation Service Product Portfolio
  54. 7.9.5 Berry Genomics Recent Developments
  55. 7.10 Brooks Life Sciences
  56. 7.10.1 Brooks Life Sciences Company Information
  57. 7.10.2 Brooks Life Sciences Business Overview
  58. 7.10.3 Brooks Life Sciences Genome Annotation Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Brooks Life Sciences Genome Annotation Service Product Portfolio
  60. 7.10.5 Brooks Life Sciences Recent Developments
  61. 7.11 Macrogen
  62. 7.11.1 Macrogen Company Information
  63. 7.11.2 Macrogen Business Overview
  64. 7.11.3 Macrogen Genome Annotation Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Macrogen Genome Annotation Service Product Portfolio
  66. 7.11.5 Macrogen Recent Developments
  67. 7.12 Personalis
  68. 7.12.1 Personalis Company Information
  69. 7.12.2 Personalis Business Overview
  70. 7.12.3 Personalis Genome Annotation Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Personalis Genome Annotation Service Product Portfolio
  72. 7.12.5 Personalis Recent Developments
  73. 7.13 Novogene
  74. 7.13.1 Novogene Company Information
  75. 7.13.2 Novogene Business Overview
  76. 7.13.3 Novogene Genome Annotation Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Novogene Genome Annotation Service Product Portfolio
  78. 7.13.5 Novogene Recent Developments
  79. 7.14 Genotypic Technology
  80. 7.14.1 Genotypic Technology Company Information
  81. 7.14.2 Genotypic Technology Business Overview
  82. 7.14.3 Genotypic Technology Genome Annotation Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Genotypic Technology Genome Annotation Service Product Portfolio
  84. 7.14.5 Genotypic Technology Recent Developments
  85. 7.15 Dna Link
  86. 7.15.1 Dna Link Company Information
  87. 7.15.2 Dna Link Business Overview
  88. 7.15.3 Dna Link Genome Annotation Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Dna Link Genome Annotation Service Product Portfolio
  90. 7.15.5 Dna Link Recent Developments
8 North America
  1. 8.1 North America Genome Annotation Service Revenue (2021-2032)
  2. 8.2 North America Genome Annotation Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Genome Annotation Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Genome Annotation Service Revenue by Type (2027-2032)
  5. 8.3 North America Genome Annotation Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Genome Annotation Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Genome Annotation Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Genome Annotation Service Revenue by Application (2027-2032)
  9. 8.5 North America Genome Annotation Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Genome Annotation Service Revenue by Country
  11. 8.6.1 North America Genome Annotation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Genome Annotation Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Genome Annotation Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Genome Annotation Service Revenue (2021-2032)
  2. 9.2 Europe Genome Annotation Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Genome Annotation Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Genome Annotation Service Revenue by Type (2027-2032)
  5. 9.3 Europe Genome Annotation Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Genome Annotation Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Genome Annotation Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Genome Annotation Service Revenue by Application (2027-2032)
  9. 9.5 Europe Genome Annotation Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Genome Annotation Service Revenue by Country
  11. 9.6.1 Europe Genome Annotation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Genome Annotation Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Genome Annotation Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Genome Annotation Service Revenue (2021-2032)
  2. 10.2 China Genome Annotation Service Revenue by Type (2021-2032)
  3. 10.2.1 China Genome Annotation Service Revenue by Type (2021-2026)
  4. 10.2.2 China Genome Annotation Service Revenue by Type (2027-2032)
  5. 10.3 China Genome Annotation Service Revenue Share by Type (2021-2032)
  6. 10.4 China Genome Annotation Service Revenue by Application (2021-2032)
  7. 10.4.1 China Genome Annotation Service Revenue by Application (2021-2026)
  8. 10.4.2 China Genome Annotation Service Revenue by Application (2027-2032)
  9. 10.5 China Genome Annotation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Genome Annotation Service Revenue (2021-2032)
  2. 11.2 Asia Genome Annotation Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Genome Annotation Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Genome Annotation Service Revenue by Type (2027-2032)
  5. 11.3 Asia Genome Annotation Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Genome Annotation Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Genome Annotation Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Genome Annotation Service Revenue by Application (2027-2032)
  9. 11.5 Asia Genome Annotation Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Genome Annotation Service Revenue by Country
  11. 11.6.1 Asia Genome Annotation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Genome Annotation Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Genome Annotation Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Genome Annotation Service Revenue (2021-2032)
  2. 12.2 SAMEA Genome Annotation Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Genome Annotation Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Genome Annotation Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Genome Annotation Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Genome Annotation Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Genome Annotation Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Genome Annotation Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Genome Annotation Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Genome Annotation Service Revenue by Country
  11. 12.6.1 SAMEA Genome Annotation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Genome Annotation Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Genome Annotation Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst